Error: Could not add to watchlist. X
+ Watchlist

Lion Biotechnologies Inc

LBIO:US
NASDAQ GM
7.00
USD
0.40
6.06%
As of 4:30 PM EST 12/9/2016
Open
6.65
Day Range
6.60 - 7.15
Volume
376,406
Previous Close
6.60
52Wk Range
4.24 - 9.58
1 Yr Return
-12.83%
Open
6.65
Day Range
6.60 - 7.15
Volume
376,406
Previous Close
6.60
52Wk Range
4.24 - 9.58
1 Yr Return
-12.83%
YTD Return
-9.33%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-1.72
Market Cap (m USD)
431.504
Shares Outstanding (m)
62.087
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
+1.23%
% Price Change
+1.47%

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
Lion Biotechnologies Inc. is engaged in the development and commercialization of a novel autologous cell therapy (ACT) for the treatment of various cancers. The Company also expects to initiate a clinical trial with its lead product candidate, which is an autologous cell therapy using TILs as a second line treatment for Stage IV metastatic melanoma.
Address
112 West 34th Street
18th Floor
New York, NY 10120
United States
Phone
1-212-946-4856
Show More